Cargando…
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261710/ http://dx.doi.org/10.1186/1750-9378-4-S2-O12 |